Michael Thomas Ropacki

Michael Thomas Ropacki

Corporate Officer/Principal at ORYZON GENOMICS S.A.

Health Technology
Consumer Services
Commercial Services

Profile

Michael Thomas Ropacki is currently the Chief Medical Officer-CNS at Oryzon Genomics SA and the President at Strategic Global Research & Development.
Previously, he worked as the Director-Clinical Development & Neuroscience at Janssen Research & Development LLC from 2013 to 2016, the Head-Global Medical Affairs at Janssen Alzheimer Immunotherapy from 2011 to 2013, and the Senior Vice President-Clinical Development at MedAvante-ProPhase, Inc. in 2017.
He holds a doctorate degree from Texas Tech University.

Michael Thomas Ropacki active positions

CompaniesPositionStart
ORYZON GENOMICS S.A. Corporate Officer/Principal 01/02/2021
Strategic Global Research & Development President -
All active positions of Michael Thomas Ropacki

Former positions of Michael Thomas Ropacki

CompaniesPositionEnd
MedAvante-ProPhase, Inc. Chief Tech/Sci/R&D Officer 01/10/2017
Chief Tech/Sci/R&D Officer 01/02/2016
Janssen Alzheimer Immunotherapy Chief Tech/Sci/R&D Officer 01/05/2013
See the detail of Michael Thomas Ropacki's experience

Training of Michael Thomas Ropacki

Texas Tech University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Thomas Ropacki's experience

Connections

24

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ORYZON GENOMICS S.A.

Health Technology

Private companies4
Janssen Alzheimer Immunotherapy

Commercial Services

MedAvante-ProPhase, Inc.

Strategic Global Research & Development

See company connections
  1. Stock Market
  2. Insiders
  3. Michael Thomas Ropacki